Molecular adsorbent recycling system in treating patients with acute liver failure: A bridge to liver transplantation

Hepatobiliary and Pancreatic Diseases International

Volumn 3, Issue 4, 2004, Pages 508-510

  Ding, Yi Tao ^a,b   Xu, Qing Xiang ^a,b   Qiu, Yu Dong ^a,b   Yang, Yi Jun ^a,b  

^a NANJING UNIVERSITY   (China)

^b Hepatobiliary Surg Inst of Nanjing   (China)

Author keywords

Acute liver failure; Artificial liver; Liver transplantation; Molecular adsorbent recycling system

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ARTIFICIAL LIVER; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BIOCHEMISTRY; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DIALYSIS MEMBRANE; FEMALE; HOSPITAL DISCHARGE; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MEDICAL INSTRUMENTATION; MOLECULAR ADSORBENT RECYCLING SYSTEM; SURGICAL TECHNIQUE; SURVIVAL; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; BILIRUBIN; FEMALE; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; SORPTION DETOXIFICATION; TIME FACTORS; TRANSAMINASES; TREATMENT OUTCOME;

EID: 9444274780     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Stange J, Mitzner S, Ramlow W, Gliesche T, Hickstein H, Schmidt R. A new procedure for the removal of protein bound drugs and toxins. ASAIO J 1993;39:621-625.
2. Campli CD, Gaspari R, Mignani V, Stifano G, Santoliquido A, Verme LZ, et al. Successful MARS treatment in severe cholestatic patients with acute on chronic liver failure. Artif Organs 2003;27:565-569.
3. Evenepoel P, Maes B, Wilmer A, Nevens F, Fevery J, Kuypers D, et al. Oxifying capacity and kinetics of the molecular adsorbent recycling system. Contribution of the different inbuilt filters. Blood Purif 2003;21:244-252.
4. Liu YH, Wang Y, Yu LX, Sun LY, Feng BL, Shen ZY, et al. Artificial liver support molecular adsorbents recirculating system therapy as a bridge to re-transplantation in two cases of long anhepatic duration. Hepatobiliary Pancreat Dis Int 2004;3:316-317.
5. Ichida T. Artificial liver support system for fulminant hepatic failure as bridge-use to living donor liver transplantation. Intern Med 2003;42:920-921.
6. van de Kerkhove MP, Di Florio E, Scuderi V, Mancini A, Belli A, Bracco A, et al. Bridging a patient with acute liver failure to liver transplantation by the AMC-bioartificial liver. Cell Transplant 2003;12:563-568.
7. Contreras J, Poniachik J, Oksenberg D, Cortes C, Valera JM, Cotera A, et al. Albumin dialysis MARS (Molecular Adsorbent Recirculating System) in acute liver failure, before liver transplantation. Report of three cases. Rev Med Chil 2004; 132: 601-607.
8. Tan HK. Molecular adsorbent recirculating system (MARS). Ann Acad Med Singapore 2004;33:329-335.
9. Ambrosino G, Naso A, Feltracco P, Carraro P, Basso SM, Varotto S, et al. Cytokines and liver failure: modification of TNF- and IL-6 in patients with acute or chronic liver decompensation treated with Molecular Adsorbent Recycling System (MARS). Acta Biomed Ateneo Parmense 2003;74:7-9.
10. Selden C, Hodgson H. Cellular therapies for liver replacement. Transpl Immunol 2004;12:273-288.
11. Santoro A, Mancini E, Buttiglieri S, Krause A, Yakubovich M, Tetta C. Extracorporeal support of liver function (II part). Int J Artif Organs 2004;27:176-185.
12. Kishino S, Takekuma Y, Sugawara M, Shimamura T, Furukawa H, Todo S, et al. Influence of continuous venovenous haemodiafiltration on the pharmacokinetics of tacrolimus in liver transplant recipients with small-for-size grafts. Clin Transplant 2003;17:412-416.
13. Adham M. Extracorporeal liver support: waiting for the deciding vote. ASAIO J 2003;49:621-632.
14. Rifai K, Ott M, Bahr MM, Schneider A, Manns MP. Liver replacement therapy. Reliable indications in acute liver failure. Internist (Berl) 2003;44:1485-1490.
15. Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, et al. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999; 23:319-330.
16. Stange J, Mitzner SR, Klammt S, Freytag J, Peszynski P, Loock J, et al. Liver support by extracorporeal blood purification: a clinical observation. Liver Transpl 2000;6:603-613.
17. Di Campli C, Zileri Dal Verme L, Andrisani MC, Armuzzi A, Candelli M, Gaspari R. Advances in extracorporeal detoxification by MARS dialysis in patients with liver failure. Curr Med Chem 2003;10:341-348.
18. Bellmann R, Graziadei IW, Feistritzer C, Schwaighofer H, Stellaard F, Sturm E, et al. Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis. Liver Transpl 2004;10:107-114.
19. Koivusalo AM, Yildirim Y, Vakkuri A, Lindgren L, Hockerstedt K, Isoniemi H. Experience with albumin dialysis in five patients with severe overdoses of paracetamol. Acta Anaesthesiol Scand 2003;47(9):1145-1150.
20. Di Campli C, Zileri Dal Verme L, Andrisani MC, Armuzzi A, Candelli M, Gaspari R, et al. Advances in extracorporeal detoxification by MARS dialysis in patients with liver failure. Curr Med Chem 2003;10:341-348.